Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2019, Article ID 5054395, 13 pages
https://doi.org/10.1155/2019/5054395
Review Article

Ginger (Zingiber officinale Roscoe) in the Prevention of Ageing and Degenerative Diseases: Review of Current Evidence

Department of Biochemistry, Faculty of Medicine, Level 17, Preclinical Building, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, 56000 Kuala Lumpur, Malaysia

Correspondence should be addressed to Suzana Makpol; ym.ude.mku.mkupp@lopkamanazus

Received 5 April 2019; Revised 10 July 2019; Accepted 24 July 2019; Published 20 August 2019

Academic Editor: Daniela Rigano

Copyright © 2019 Nur Fatin Nabilah Mohd Sahardi and Suzana Makpol. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. López-Otín, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, “The hallmarks of aging,” Cell, vol. 153, no. 6, pp. 1194–1217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Nations, “Ageing,” 2017, http://www.un.org/en/sections/issues-depth/ageing/. View at Google Scholar
  3. S. A. Rashid, P. A. Ghani, and N. Daud, “Population trends in Malaysia: 1970–2010,” in Proceedings of the AIP Conference Proceedings, AIP, Surakarta, Indonesia, 2014.
  4. M. Ferry and A.-M. Roussel, “Micronutrient status and cognitive decline in ageing,” European Geriatric Medicine, vol. 2, no. 1, pp. 15–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. A. Hamid, Y. A. Momtaz, and R. Ibrahim, “Predictors and prevalence of successful aging among older Malaysians,” Gerontology, vol. 58, no. 4, pp. 366–370, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Naylor, D. J. Baker, and J. M. van Deursen, “Senescent cells: a novel therapeutic target for aging and age-related diseases,” Clinical Pharmacology & Therapeutics, vol. 93, no. 1, pp. 105–116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Campisi, J. K. Andersen, P. Kapahi, and S. Melov, “Cellular senescence: a link between cancer and age-related degenerative disease?” Seminars in Cancer Biology, vol. 21, no. 6, pp. 354–359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Stambler, “Recognizing degenerative aging as a treatable medical condition: methodology and policy,” Aging and Disease, vol. 8, no. 5, p. 583, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Sikora, T. Arendt, M. Bennett, and M. Narita, “Impact of cellular senescence signature on ageing research,” Ageing Research Reviews, vol. 10, no. 1, pp. 146–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Inouye, S. Studenski, M. E. Tinetti, and G. A. Kuchel, “Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept,” Journal of the American Geriatrics Society, vol. 55, no. 5, pp. 780–791, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Palipoch and P. Koomhin, “Oxidative stress-associated pathology: a review,” Sains Malaysiana, vol. 44, no. 10, pp. 1441–1451, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Phaniendra, D. B. Jestadi, and L. Periyasamy, “Free radicals: properties, sources, targets, and their implication in various diseases,” Indian Journal of Clinical Biochemistry, vol. 30, no. 1, pp. 11–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Suzuki, N. Fujita, N. Hosogane et al., “Excessive reactive oxygen species are therapeutic targets for intervertebral disc degeneration,” Arthritis Research & Therapy, vol. 17, no. 1, p. 316, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Khansari, Y. Shakiba, and M. Mahmoudi, “Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer,” Recent Patents on Inflammation & Allergy Drug Discovery, vol. 3, no. 1, pp. 73–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Ayala, M. F. Muñoz, and S. Argüelles, “Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 360438, p. 31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Mittal, M. R. Siddiqui, K. Tran, S. P. Reddy, and A. B. Malik, “Reactive oxygen species in inflammation and tissue injury,” Antioxidants & Redox Signaling, vol. 20, no. 7, pp. 1126–1167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Lingappan, “NF-κB in oxidative stress,” Current Opinion in Toxicology, vol. 7, pp. 81–86, 2018. View at Publisher · View at Google Scholar · View at Scopus
  18. M. H. Park and J. T. Hong, “Roles of NF-kB in cancer and inflammatory diseases and their therapeutic approaches,” Cells, vol. 5, no. 2, p. 15, 2016. View at Publisher · View at Google Scholar
  19. A. Kriete, K. L. Mayo, N. Yalamanchili et al., “Cell autonomous expression of inflammatory genes in biologically aged fibroblasts associated with elevated NF-kappaB activity,” Immun Ageing, vol. 5, no. 1, p. 5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Ramalingam and S.-J. Kim, “Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases,” Journal of Neural Transmission, vol. 119, no. 8, pp. 891–910, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Padurariu, A. Ciobica, L. Hritcu, B. Stoica, W. Bild, and C. Stefanescu, “Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease,” Neuroscience Letters, vol. 469, no. 1, pp. 6–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Sharifi and S. H. Mousavi, “Studying the effects of lead on DNA fragmentation and proapoptotic Bax and antiapoptotic Bcl-2 protein expression in PC12 cells,” Toxicology Mechanisms and Methods, vol. 18, no. 1, pp. 75–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Sanada, Y. Taniyama, J. Muratsu et al., “Source of chronic inflammation in aging,” Frontiers in Cardiovascular Medicine, vol. 5, p. 12, 2018. View at Publisher · View at Google Scholar
  24. K. S. Petersen and C. Smith, “Ageing-associated oxidative stress and inflammation are alleviated by products from grapes,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 6236309, p. 12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Salminen, J. Huuskonen, J. Ojala, A. Kauppinen, K. Kaarniranta, and T. Suuronen, “Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging,” Ageing Research Reviews, vol. 7, no. 2, pp. 83–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Singh and A. B. Newman, “Inflammatory markers in population studies of aging,” Ageing Research Reviews, vol. 10, no. 3, pp. 319–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Beyer, T. Mets, and I. Bautmans, “Chronic low-grade inflammation and age-related sarcopenia,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 15, no. 1, pp. 12–22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Sultana and D. A. Butterfield, “Role of oxidative stress in the progression of Alzheimer’s disease,” Journal of Alzheimer’s Disease, vol. 19, no. 1, pp. 341–353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. M. Bekris, C.-E. Yu, T. D. Bird, and D. W. Tsuang, “Review article: genetics of alzheimer disease,” Journal of Geriatric Psychiatry and Neurology, vol. 23, no. 4, pp. 213–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. B. T. Tung, D. K. Thu, N. T. K. Thu, and N. T. Hai, “Antioxidant and acetylcholinesterase inhibitory activities of ginger root (Zingiber officinale Roscoe) extract,” Journal of Complementary and Integrative Medicine, vol. 14, no. 4, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. M. F. Beal, “Oxidatively modified proteins in aging and disease,” Free Radical Biology and Medicine, vol. 32, no. 9, pp. 797–803, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. T. I. Williams, B. C. Lynn, W. R. Markesbery, and M. A. Lovell, “Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer’s disease,” Neurobiology of Aging, vol. 27, no. 8, pp. 1094–1099, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. H. C. Çubukçu, M. Yurtdaş, Z. E. Durak et al., “Oxidative and nitrosative stress in serum of patients with Parkinson’s disease,” Neurological Sciences, vol. 37, no. 11, pp. 1793–1798, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. O.-B. Tysnes and A. Storstein, “Epidemiology of Parkinson’s disease,” Journal of Neural Transmission, vol. 124, no. 8, pp. 901–905, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Pimentel, L. Batista-Nascimento, C. Rodrigues-Pousada, and R. A. Menezes, “Oxidative stress in Alzheimer’s and Parkinson’s diseases: insights from the yeast Saccharomyces cerevisiae,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 132146, p. 9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. S. Medeiros, A. Schumacher-Schuh, A. M. Cardoso et al., “Iron and oxidative stress in Parkinson’s disease: an observational study of injury biomarkers,” PLoS One, vol. 11, no. 1, Article ID e0146129, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Tosukhowong, C. Boonla, T. Dissayabutra et al., “Biochemical and clinical effects of Whey protein supplementation in Parkinson’s disease: a pilot study,” Journal of the Neurological Sciences, vol. 367, pp. 162–170, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. G. K. Hansson and A. Hermansson, “The immune system in atherosclerosis,” Nature Immunology, vol. 12, no. 3, pp. 204–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Peluso, G. Morabito, L. Urban, F. Ioannone, and M. Serafi, “Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst,” Endocrine, Metabolic & Immune Disorders-Drug Targets, vol. 12, no. 4, pp. 351–360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. M. Zafari, M. Ushio-Fukai, M. Akers et al., “Role of NADH/NADPH oxidase–derived H2O2in angiotensin II-induced vascular hypertrophy,” Hypertension, vol. 32, no. 3, pp. 488–495, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. A. R. Brasier, “The nuclear factor-κB–interleukin-6 signalling pathway mediating vascular inflammation,” Cardiovascular Research, vol. 86, no. 2, pp. 211–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. O. R. Temneanu, L. M. Trandafir, and M. R. Purcarea, “Type 2 diabetes mellitus in children and adolescents: a relatively new clinical problem within pediatric practice,” Journal of Medicine and Life, vol. 9, no. 3, pp. 235–239, 2016. View at Google Scholar
  43. F. Shidfar, A. Rajab, T. Rahideh, N. Khandouzi, S. Hosseini, and S. Shidfar, “The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes,” Journal of Complementary and Integrative Medicine, vol. 12, no. 2, pp. 165–170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich, “Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species,” Physiological Reviews, vol. 89, no. 1, pp. 27–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Bloch-Damti and N. Bashan, “Proposed mechanisms for the induction of insulin resistance by oxidative stress,” Antioxidants & Redox Signaling, vol. 7, no. 11-12, pp. 1553–1567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. A. M. Cardoso, F. H. Abdalla, M. D. Bagatini et al., “Swimming training prevents alterations in acetylcholinesterase and butyrylcholinesterase activities in hypertensive rats,” American Journal of Hypertension, vol. 27, no. 4, pp. 522–529, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Ahmad, U. Singhal, M. M. Hossain, N. Islam, and I. Rizvi, “The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension,” Journal of Clinical and Diagnostic Research, vol. 7, no. 6, pp. 987–990, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. E. C. Li, B. S. Heran, and J. M. Wright, “Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension,” Cochrane Database of Systematic Reviews, no. 8, Article ID Cd009096, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Mann, “Biopotency role of culinary spices and herbs and their chemical constituents in health and commonly used spices in Nigerian dishes and snacks,” African Journal of Food Science, vol. 5, no. 3, pp. 111–124, 2011. View at Google Scholar
  50. T. Arablou, N. Aryaeian, M. Valizadeh, F. Sharifi, A. Hosseini, and M. Djalali, “The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus,” International Journal of Food Sciences and Nutrition, vol. 65, no. 4, pp. 515–520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Ansari, P. Porouhan, M. Mohammadianpanah et al., “Efficacy of ginger in control of chemotherapy induced nausea and vomiting in breast cancer patients receiving doxorubicin-based chemotherapy,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 8, pp. 3877–3880, 2016. View at Google Scholar
  52. M. Maghbooli, F. Golipour, A. M. Esfandabadi, and M. Yousefi, “Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine,” Phytotherapy Research, vol. 28, no. 3, pp. 412–415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Tanaka, M. Arita, H. Sakurai, N. Ono, and Y. Tezuka, “Analysis of chemical properties of edible and medicinal ginger by metabolomics approach,” BioMed Research International, vol. 2015, Article ID 671058, p. 7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Park, J. Bae, and D.-S. Lee, “Antibacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria,” Phytotherapy Research, vol. 22, no. 11, pp. 1446–1449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. R. B. van Breemen, Y. Tao, and W. Li, “Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale),” Fitoterapia, vol. 82, no. 1, pp. 38–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. A. S. Chakotiya, A. Tanwar, A. Narula, and R. K. Sharma, “Zingiber officinale: its antibacterial activity on Pseudomonas aeruginosa and mode of action evaluated by flow cytometry,” Microbial Pathogenesis, vol. 107, pp. 254–260, 2017. View at Publisher · View at Google Scholar · View at Scopus
  57. M. C. Valera, F. G. d. R. Cardoso, L. E. Maekawa, C. H. R. Camargo, L. D. de Oliveira, and C. A. T. Carvalho, “In vitro antimicrobial and anti-endotoxin action of Zingiber Officinaleas auxiliary chemical and medicament combined to calcium hydroxide and chlorhexidine,” Acta Odontologica Scandinavica, vol. 73, no. 7, pp. 556–561, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Malu, G. O. Obochi, E. N. Tawo, and B. E. Nyong, “Antibacterial activity and medicinal properties of ginger (Zingiber officinale),” Global Journal of Pure and Applied Sciences, vol. 15, no. 3-4, 2009. View at Publisher · View at Google Scholar
  59. U. Ekwenye and N. Elegalam, “Antibacterial activity of ginger (Zingiber officinale Roscoe) and garlic (Allium sativum L.) extracts on Escherichia coli and Salmonella typhi,” International Journal of Molecular Medicine and Advance Sciences, vol. 1, no. 4, pp. 411–416, 2005. View at Google Scholar
  60. P. Karuppiah and S. Rajaram, “Antibacterial effect of Allium sativum cloves and Zingiber officinale rhizomes against multiple-drug resistant clinical pathogens,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 8, pp. 597–601, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Pashaei-Asl, F. Pashaei-Asl, P. M. Gharabaghi et al., “The inhibitory effect of ginger extract on ovarian cancer cell line; application of systems biology,” Advanced Pharmaceutical Bulletin, vol. 7, no. 2, pp. 241–249, 2017. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Saha, J. Blando, E. Silver, L. Beltran, J. Sessler, and J. DiGiovanni, “6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-κB signaling,” Cancer Prevention Research, vol. 7, no. 6, pp. 627–638, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. S. M. Ezzat, M. I. Ezzat, M. M. Okba, E. T. Menze, and A. B. Abdel-Naim, “The hidden mechanism beyond ginger (Zingiber officinale Rosc.) potent in vivo and in vitro anti-inflammatory activity,” Journal of Ethnopharmacology, vol. 214, pp. 113–123, 2018. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. M. Al-Amin, M. Thomson, K. K. Al-Qattan, R. Peltonen-Shalaby, and M. Ali, “Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats,” British Journal of Nutrition, vol. 96, no. 4, pp. 660–666, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. V. B. Liju, K. Jeena, and R. Kuttan, “Gastroprotective activity of essential oils from turmeric and ginger,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 26, no. 1, pp. 95–103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. W. Si, Y. P. Chen, J. Zhang, Z.-Y. Chen, and H. Y. Chung, “Antioxidant activities of ginger extract and its constituents toward lipids,” Food Chemistry, vol. 239, pp. 1117–1125, 2018. View at Publisher · View at Google Scholar · View at Scopus
  67. P. R. S. Adel and J. Prakash, “Chemical composition and antioxidant properties of ginger root (Zingiber officinale),” Journal of Medicinal Plants Research, vol. 4, no. 24, pp. 2674–2679, 2010. View at Publisher · View at Google Scholar
  68. U. K. Hussein, N. Hassan, M. Elhalwagy et al., “Ginger and propolis exert neuroprotective effects against monosodium glutamate-induced neurotoxicity in rats,” Molecules, vol. 22, no. 11, 2017. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Sebiomo, A. D. Awofodu, A. O. Awosanya, F. E. Awotona, and A. J. Ajayi, “Comparative studies of antibacterial effect of some antibiotics and ginger (Zingiber officinale) on two pathogenic bacteria,” Journal of Microbiology and Antimicrobials, vol. 3, no. 1, pp. 18–22, 2011. View at Google Scholar
  70. Z. Zainal-Abidin, N. A. Abdul-Wahab, M. K. Ghazi-Ahmad, S. Mohd-Said et al., “In vitro antibacterial activity of Zingiber officinale and Orthosiphon stamineus on Enterococcus faecalis,” Journal of Agricultural Science, vol. 9, no. 13, pp. 112–121, 2017. View at Publisher · View at Google Scholar
  71. M. Maizura, A. Aminah, and W. M. Wan Aida, “Total phenolic content and antioxidant activity of kesum (Polygonum minus), ginger (Zingiber officinale) and turmeric (Curcuma longa) extract,” International Food Research Journal, vol. 18, no. 2, pp. 529–534, 2011. View at Google Scholar
  72. Y. A. M. Yusof and A. Abdul-Aziz, “Effects of Zingiber officinale on superoxide dismutase, glutathione peroxidase, catalase, glutathione and malondialdehyde content in HepG2 cell line,” Malaysian Journal of Biochemistry and Molecular Biology, vol. 11, pp. 36–41, 2005. View at Google Scholar
  73. S. Mahluji, A. Ostadrahimi, M. Mobasseri, V. Ebrahimzade Attari, and L. Payahoo, “Anti-inflammatory effects of Zingiber officinale in type 2 diabetic patients,” Advanced Pharmaceutical Bulletin, vol. 3, no. 2, pp. 273–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Mozaffari-Khosravi, Z. Naderi, A. Dehghan, A. Nadjarzadeh, and H. F. Huseini, “Effect of ginger supplementation on proinflammatory cytokines in older patients with osteoarthritis: outcomes of a randomized controlled clinical trial,” Journal of Nutrition in Gerontology and Geriatrics, vol. 35, no. 3, pp. 209–218, 2016. View at Publisher · View at Google Scholar · View at Scopus
  75. R. A. Kulkarni and A. R. Deshpande, “Anti-inflammatory and antioxidant effect of ginger in tuberculosis,” Journal of Complementary and Integrative Medicine, vol. 13, no. 2, pp. 201–206, 2016. View at Publisher · View at Google Scholar · View at Scopus
  76. G. El-Akabawy and W. El-Kholy, “Neuroprotective effect of ginger in the brain of streptozotocin-induced diabetic rats,” Annals of Anatomy-Anatomischer Anzeiger, vol. 196, no. 2-3, pp. 119–128, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Shanmugam, K. Mallikarjuna, N. Kesireddy, and K. S. Reddy, “Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats,” Food and Chemical Toxicology, vol. 49, no. 4, pp. 893–897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. S. O. Kim, K.-S. Chun, J. K. Kundu, and Y.-J. Surh, “Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-κB and p38 MAPK in mouse skin,” Biofactors, vol. 21, no. 1–4, pp. 27–31, 2004. View at Publisher · View at Google Scholar
  79. N. Miyoshi, Y. Nakamura, Y. Ueda et al., “Dietary ginger constituents, galanals A and B, are potent apoptosis inducers in Human T lymphoma Jurkat cells,” Cancer Letters, vol. 199, no. 2, pp. 113–119, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Yasmin Anum, Z. A. Shahriza, M. L. Looi et al., “Ginger extract (Zingiber officinale Roscoe) triggers apoptosis in hepatocarcinogenesis induced rats,” Medicine & Health, vol. 3, no. 2, pp. 263–274, 2008. View at Google Scholar
  81. L. Hakim, E. Alias, S. Makpol, W. Z. W. Ngah, N. A. Morad, and Y. A. M. Yusof, “Gelam honey and ginger potentiate the anti cancer effect of 5-FU against HCT 116 colorectal cancer cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 11, pp. 4651–4657, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Romero, M. Forero, L. G. Sequeda-Castañeda et al., “Effect of ginger extract on membrane potential changes and AKT activation on a peroxide-induced oxidative stress cell model,” Journal of King Saud University—Science, vol. 30, no. 2, pp. 263–269, 2018. View at Publisher · View at Google Scholar · View at Scopus
  83. A. J. Akinyemi, A. O. Ademiluyi, and G. Oboh, “Aqueous extracts of two varieties of ginger (Zingiber officinale) inhibit angiotensin I-converting enzyme, iron(II), and sodium nitroprusside-induced lipid peroxidation in the rat heart in vitro,” Journal of Medicinal Food, vol. 16, no. 7, pp. 641–646, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Hosseinzadeh, K. B. Juybari, M. J. Fatemi et al., “Protective effect of ginger (Zingiber officinale roscoe) extract against oxidative stress and mitochondrial apoptosis induced by interleukin-1β in cultured chondrocytes,” Cells Tissues Organs, vol. 204, no. 5-6, pp. 241–250, 2017. View at Publisher · View at Google Scholar · View at Scopus
  85. K. R. Shanmugam, K. Mallikarjuna, K. Nishanth, C. H. Kuo, and K. S. Reddy, “Protective effect of dietary ginger on antioxidant enzymes and oxidative damage in experimental diabetic rat tissues,” Food Chemistry, vol. 124, no. 4, pp. 1436–1442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. C. M. Thomas, C. J. Fuller, C. E. Whittles, and M. Sharif, “Chondrocyte death by apoptosis is associated with cartilage matrix degradation,” Osteoarthritis and Cartilage, vol. 15, no. 1, pp. 27–34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. S. S. Asl, B. Pourheydar, F. Dabaghian, A. Nezhadi, A. Roointan, and M. Mehdizadeh, “Ecstasy-induced caspase expression alters following ginger treatment,” Basic and Clinical Neuroscience, vol. 4, no. 4, pp. 329–333, 2013. View at Google Scholar
  88. S. Peng, J. Yao, Y. Liu, D. Duan, X. Zhang, and J. Fang, “Activation of Nrf2 target enzymes conferring protection against oxidative stress in PC12 cells by ginger principal constituent 6-shogaol,” Food & Function, vol. 6, no. 8, pp. 2813–2823, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. J.-M. Lee, J. Li, D. A. Johnson et al., “Nrf2, a multi-organ protector?” The FASEB Journal, vol. 19, no. 9, pp. 1061–1066, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. Q. Ma, “Role of Nrf2 in oxidative stress and toxicity,” Annual Review of Pharmacology and Toxicology, vol. 53, no. 1, pp. 401–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. I. M. Copple, “The Keap1–Nrf2 cell defense pathway–a promising therapeutic target?” in Advances in Pharmacology, Elsevier, Amsterdam, Netherlands, 2012. View at Google Scholar
  92. B. Ilkhanizadeh, A. Shirpoor, M. h. Khadem Ansari, S. Nemati, and Y. Rasmi, “Protective effects of ginger (Zingiber officinale) extract against diabetes-induced heart abnormality in rats,” Diabetes & Metabolism Journal, vol. 40, no. 1, pp. 46–53, 2016. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Wang, S. Sjöberg, T.-T. Tang et al., “Cathepsin G activity lowers plasma LDL and reduces atherosclerosis,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1842, no. 11, pp. 2174–2183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  94. S. K. Verma, M. Singh, P. Jain, and A. Bordia, “Protective effect of ginger, Zingiber officinale Rosc on experimental atherosclerosis in rabbits,” Indian Journal of Experimental Biology, vol. 42, no. 7, pp. 736–738, 2004. View at Google Scholar
  95. A. Shirpoor, F. H. Gharalari, Y. Rasmi, and E. Heshmati, “Ginger extract attenuates ethanol-induced pulmonary histological changes and oxidative stress in rats,” Journal of Biomedical Research, vol. 31, no. 6, pp. 521–527, 2017. View at Publisher · View at Google Scholar · View at Scopus
  96. C.-Y. Kim, Y. Seo, C. Lee, G. H. Park, and J.-H. Jang, “Neuroprotective effect and molecular mechanism of [6]-Gingerol against scopolamine-induced amnesia in C57BL/6 mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2018, Article ID 8941564, p. 11, 2018. View at Publisher · View at Google Scholar · View at Scopus
  97. N. Saenghong, J. Wattanathorn, S. Muchimapura et al., “Zingiber officinale improves cognitive function of the middle-aged healthy women,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 383062, p. 9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. G. S. E. Working, “Memory of the post-menopause women,” American Journal of Applied Sciences, vol. 8, no. 12, pp. 1241–1248, 2011. View at Google Scholar
  99. M. N. Ghayur, A. H. Gilani, T. Ahmed et al., “Muscarinic, Ca++ antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia,” Journal of Pharmacy and Pharmacology, vol. 60, no. 10, pp. 1375–1383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Gomar, A. Hosseini, and N. Mirazi, “Memory enhancement by administration of ginger (Zingiber officinale) extract on morphine-induced memory impairment in male rats,” Journal of Acute Disease, vol. 3, no. 3, pp. 212–217, 2014. View at Publisher · View at Google Scholar
  101. J. Wattanathorn, J. Jittiwat, T. Tongun, S. Muchimapura, and K. Ingkaninan, “Zingiber officinale mitigates brain damage and improves memory impairment in focal cerebral ischemic rat,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 429505, p. 8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. C. Lee, G. H. Park, C.-Y. Kim, and J.-H. Jang, “[6]-Gingerol attenuates β-amyloid-induced oxidative cell death via fortifying cellular antioxidant defense system,” Food and Chemical Toxicology, vol. 49, no. 6, pp. 1261–1269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. G.-f. Zeng, Z.-y. Zhang, L. Lu, D.-q. Xiao, S.-h. Zong, and J.-m. He, “Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats,” Rejuvenation Research, vol. 16, no. 2, pp. 124–133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. A. M. Karam, N. A. Gouda, A. E.-F. H. Marrie et al., “Protective effect of ginger (Zingiber officinale) on Alzheimer’s disease induced in rats,” Journal of Neuroinfectious Diseases, vol. 5, no. 159, p. 2, 2014. View at Google Scholar
  105. M. Moon, H. G. Kim, J. G. Choi et al., “6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia,” Biochemical and Biophysical Research Communications, vol. 449, no. 1, pp. 8–13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. G. Park, H. G. Kim, M. S. Ju et al., “6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via anti-neuroinflammation,” Acta Pharmacologica Sinica, vol. 34, no. 9, pp. 1131–1139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. S. K. Ha, E. Moon, M. S. Ju et al., “6-Shogaol, a ginger product, modulates neuroinflammation: a new approach to neuroprotection,” Neuropharmacology, vol. 63, no. 2, pp. 211–223, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. G. Oboh, A. J. Akinyemi, A. O Ademiluyi, and S. Adefegha, “Inhibitory effects of aqueous extract of two varieties of ginger on some key enzymes linked to type-2 diabetes in vitro,” Journal of Food and Nutrition Research, vol. 49, no. 1, pp. 14–20, 2010. View at Google Scholar
  109. A. J. Akinyemi, A. O. Ademiluyi, and G. Oboh, “Inhibition of angiotensin-1-converting enzyme activity by two varieties of ginger (Zingiber officinale) in rats fed a high cholesterol diet,” Journal of Medicinal Food, vol. 17, no. 3, pp. 317–323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Ribel-Madsen, E. M. Bartels, A. Stockmarr et al., “A synoviocyte model for osteoarthritis and rheumatoid arthritis: response to Ibuprofen, betamethasone, and ginger extract-a cross-sectional in vitro study,” Arthritis, vol. 2012, Article ID 505842, p. 9, 2012. View at Publisher · View at Google Scholar
  111. Z. Naderi, H. Mozaffari-Khosravi, A. Dehghan, A. Nadjarzadeh, and H. F. Huseini, “Effect of ginger powder supplementation on nitric oxide and C-reactive protein in elderly knee osteoarthritis patients: a 12-week double-blind randomized placebo-controlled clinical trial,” Journal of Traditional and Complementary Medicine, vol. 6, no. 3, pp. 199–203, 2016. View at Publisher · View at Google Scholar · View at Scopus
  112. Z. Zakeri, S. Izadi, Z. Bari, F. Soltan, B. Narouie, and M. Ghasemi-rad, “Evaluating the effects of ginger extract on knee pain, stiffness and difficulty in patients with knee osteoarthritis,” Journal of Medicinal Plants Research, vol. 5, no. 15, pp. 3375–3379, 2011. View at Google Scholar
  113. H. Rouhi-Boroujeni, M. Gharipour, M. Asadi-Samani, and H. Rouhi-Boroujeni, “The protective effects of ginger on the development of coronary atherosclerosis: an experimental animal study,” Der Pharmacia Lettre, vol. 8, no. 3, pp. 105–109, 2016. View at Google Scholar
  114. B. Fuhrman, M. Rosenblat, T. Hayek, R. Coleman, and M. Aviram, “Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice,” The Journal of Nutrition, vol. 130, no. 5, pp. 1124–1131, 2000. View at Publisher · View at Google Scholar
  115. S. Wang, M. Tian, R. Yang et al., “6-Gingerol ameliorates behavioral changes and atherosclerotic lesions in ApoE–/– mice exposed to chronic mild stress,” Cardiovascular Toxicology, vol. 18, no. 5, pp. 420–430, 2018. View at Publisher · View at Google Scholar · View at Scopus
  116. H.-C. Wu, C.-T Horng, S.-C Tsai et al., “Relaxant and vasoprotective effects of ginger extracts on porcine coronary arteries,” International Journal of Molecular Medicine, vol. 41, no. 4, pp. 2420–2428, 2018. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Sanghal, K. K. Pant, S. M. Natu, A. Nischal, S. Khattri, and R. Nath, “An experimental study to evaluate the preventive effect of Zingiber officinale (ginger) on hypertension and hyperlipidaemia and its comparison with Allium sativum (garlic) in rats,” Journal of Medicinal Plants Research, vol. 6, no. 25, pp. 4231–4238, 2012. View at Google Scholar
  118. Y. Wang, H. Yu, X. Zhang et al., “Evaluation of daily ginger consumption for the prevention of chronic diseases in adults: a cross-sectional study,” Nutrition, vol. 36, pp. 79–84, 2017. View at Publisher · View at Google Scholar · View at Scopus